EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition

Xiaojuan Li, Fan Wang, Xiaolin Zhang, Qinqin Sun, Ersheng Kuang iD

PLOS Pathogens · 2023

DOI: 10.1371/journal.ppat.1011103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Xiaojuan Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Lymphoma, Primary Effusion, Herpesviridae Infections, Sarcoma, Kaposi. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary effusion lymphoma (PEL), a rare aggressive B-cell lymphoma in immunosuppressed patients, is etiologically associated with oncogenic γ-herpesvirus infection. Chemotherapy is commonly used to treat PEL but usually results in poor prognosis and survival; thus, novel therapies and drug development are urgently needed for PEL treatment. Here, we demonstrated that inhibition of Ring finger protein 5 (RNF5), an ER-localized E3 ligase, suppresses multiple cellular pathways and lytic replication of Kaposi sarcoma-associated herpesvirus (KSHV) in PEL cells. RNF5 interacts with and induces Ephrin receptors A3 (EphA3) and EphA4 ubiquitination and degradation. RNF5 inhibition increases the levels of EphA3 and EphA4, thereby reducing ERK and Akt activation and KSHV lytic replication. RNF5 inhibition decreased PEL xenograft tumor growth and downregulated viral gene expression, cell cycle gene expression, and hedgehog signaling in xenograft tumors. Our study suggests that RNF5 plays the critical roles in KSHV lytic infection and tumorigenesis of primary effusion lymphoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 8, HumanLymphoma, Primary EffusionHerpesviridae InfectionsSarcoma, KaposiHumansHedgehog ProteinsSignal TransductionCell Line, TumorVirus ReplicationDNA-Binding ProteinsUbiquitin-Protein Ligases

Substanzen

Hedgehog ProteinsRNF5 protein, humanDNA-Binding ProteinsUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
  • College of Clinical Medicine, Hubei University of Chinese Medicine, Wuhan, China.
  • Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou, China.

ORCID-Profile: Ersheng Kuang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, X., Wang, F., Zhang, X., Sun, Q., & Kuang, E. (2023). Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011103

Vancouver

Li X, Wang F, Zhang X, Sun Q, Kuang E. Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011103

BibTeX
@article{Li2023,
  author = {Li, Xiaojuan and Wang, Fan and Zhang, Xiaolin and Sun, Qinqin and Kuang, Ersheng},
  title = {Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition},
  journal = {PLOS Pathogens},
  year = {2023},
  doi = {10.1371/journal.ppat.1011103}
}
Kostenlos starten →